Wataru Endo has given an update on his future at Liverpool, amidst reports linking him with a move away from the club ...

Long-term efficacy and safety data on PALSONIFYTM (paltusotine) in acromegaly to be presented, including evidence of both ...

GOSSELIES, Belgium & DUBAI, United Arab Emirates, June 30, 2025--Endo Tools Therapeutics (ETT), a company developing and marketing advanced endoscopic medical devices, and Fujifilm Middle East FZE, a ...

Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the ...

Liverpool midfielder Wataru Endo has hinted that he will be staying at Anfield for the 2025-26 campaign amid speculation surrounding his next career move. The Japan international has never managed to ...

Efficacy and Safety of Setmelanotide in Acquired Hypothalamic Obesity: Results from a Double-Blind, Multicenter, Placebo-Controlled, Randomized Phase 3 Trial July 12, 2025, 2:00 PM - 2:15 PM PT ...

Endo Tools Therapeutics (ETT), a company developing and marketing advanced endoscopic medical devices, and Fujifilm Middle East FZE, a subsidiary of FUJIFILM ...

Jarell Quansah has completed his move from Liverpool to Bayer Leverkusen on a five-year deal through to 2030. Liverpool say ...

MALVERN, Pa., June 17, 2025 /CNW/ -- Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI) today announced that it has completed the previously announced divestiture of its International ...

Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, ...